Regeneron Pharmaceuticals Inc. (REGN)
Q4 2011 Earnings Call
February 13, 2012 8:30 am ET
Dr. Leonard Schleifer – President, Chief Executive Officer
Murray Goldberg – Chief Financial Officer
Robert Terifay – Senior Vice President, Commercial
Dr. Michael Aberman – Vice President, Strategy and Investor Relations
Jim Birchenough – BMO Capital
Jason Kantor – RBC Capital Markets
Josh Schimmer – Leerink Swann
Alethia Young – Deutsche Bank
Chris Raymond – Robert W. Baird
Steve Byrne – Bank of America
Biren Amin – Jefferies
Mani Mohindru – ThinkEquity
Yaron Werber - Citigroup
Geoff Meacham – JP Morgan
Phil Nadeau – Cowen & Company
Good morning ladies and gentlemen. Welcome to the Regeneron Pharmaceuticals Conference Call to discuss the fourth quarter and full-year 2011 financial results. My name is Latoya and I’ll be your coordinator for today. At this time, all participants are in a listen-only mode. We will conduct a question and answer session towards the end of the call. As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Dr. Aberman, Vice President of Strategy and Investor Relations for Regeneron. Please proceed, Dr. Aberman.
Dr. Michael Aberman
Thank you very much. Good morning and welcome to Regeneron Pharmaceuticals’ Fourth Quarter and Full-Year 2011 conference call. An archive of this webcast will be available on our website under Events and Presentations for 30 days.
Joining me on the call today is Dr. Leonard Schleifer, Founder, President and Chief Executive Officer; Murray Goldberg, Chief Financial Officer; and Robert Terifay, Senior Vice President, Commercial. After our prepared remarks, we will open the call for questions and answers.